Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001311655 | SCV001501928 | pathogenic | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001871779 | SCV002203126 | pathogenic | Familial hemiplegic migraine | 2022-12-02 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1013256). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg604*) in the ATP1A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP1A2 are known to be pathogenic (PMID: 30690204). |